CeDAR Symposium
VITAMIN D AND CARDIOVASCULAR DISEASE
October 17-18, 2008
Day 1: Friday October 17, 2008
7:30-8:00 AM CONTINENTAL BREAKFAST
8:00-8:15 AM Introduction / Welcome
Ravi Thadhani – Harvard
8:15-8:45 AM Vitamin D deficiency and CVD outcomes: The epidemiologic evidence
Erin Michos – Johns Hopkins
8:55-9:20 PM Clinical trials of vitamin D and CVD outcomes in the general population
Carlos Camargo – Harvard
Robert Scragg – University of Auckland, New Zealand
9:30-10:00 AM Genomic and non-genomic actions of vitamin D
Anthony Norman – UC Riverside
10:15-10:30 AM BREAK
10:30-10:55 AM Stalking the VDR: Vitamin D’s effects on cardiac contractility, hypertrophy, fibrosis and blood pressure
Robert Simpson – University of Michigan
11:05-11:25 AM Overview of endothelium-derived contracting factor
Paul Vanhoutte – University of Hong Kong
11:25-11:35 AM Vitamin D 3 reduces endothelium-dependent contraction in the aorta of the spontaneously hypertensive rat
Michael Wong – University of Hong Kong
11:45-12:45 PM LUNCH
12:45-1:10 PM Vitamin D, the renin-angiotensin system, and cardiac hypertrophy: Causal or correlates?
Yan Li – University of Chicago
1:20-1:40 PM Vitamin D action in the heart and vasculature
David Gardner – UCSF
1:50-2:10 PM Cardiac hypertrophy and rescue in the 1-alpha hydroxylase KO model
David Goltzman – McGill University
2:20-2:40 PM Cardio-renal effects of vitamin D
Eduardo Slatopolsky – Washington University
2:40-3:00 PM Renal and vascular axis in kidney disease
Adriana Dusso – Washington University
3:15-3:30 PM BREAK
3:30-3:45 PM Cardiac hypertrophy: Planning clinical trials
Ravi Thadhani – Harvard
3:55-4:15 PM Vitamin D status and under-represented minorities
Sherri Ann Burnett-Bowie – Harvard
4:15-4:35 PM CVD and CKD in under-represented minorities
Keith Norris – UCLA
4:50-5:00 PM Wrap-up / Announcements
5:00-6:30 PM BREAK
6:30 PM DINNER AT THE MUSEUM OF SCIENCE ( www.mos.org)
7:00 PM Dinner Speaker: Michael Holick – Boston University
Day 2: Saturday October 18, 2008
7:30-8:00 AM CONTINENTAL BREAKFAST
8:00-8:20 AM Vitamin D and macrophage function
Martin Hewison – UCLA
8:30-8:50 AM Vitamin D and inflammation
Chantal Mathieu – University of Leuven, Belgium
9:00-9:20 AM Vitamin D, metabolism, and CVD
Alp Ikizler – Vanderbilt
9:30-9:50 AM Fibroblast growth factor-23 in chronic kidney disease
Myles Wolf – University of Miami
10:00-10:15 AM BREAK
10:15-10:45 AM Vitamin D in heart failure
Armin Zittermann – Heart Center NRW, Germany
10:55-11:20 PM Is there “room” for vitamin D among CVD therapies?
Thomas Wang – Framingham Heart Study
11:20-12:00 AM Discussion / Next steps
Carlos Camargo – Harvard
Erin Michos – Johns Hopkins
Ravi Thadhani – Harvard
12:00 PM Adjourn
|